Viewing Study NCT00136604

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:11 PM

Ignite Modification Date: 2025-12-25 @ 7:01 PM

Study NCT ID: NCT00136604

Status: COMPLETED

Last Update Posted: 2020-02-20

First Post: 2005-08-26

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Sponsor: GlaxoSmithKline

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module